Home » Topics » BioWorld Science

BioWorld Science
RSS

Antischistosomal agent derived from myrrh tested in humans

Jan. 21, 1998

European filing announced for Savedar (DepoCyt)

Jan. 21, 1998

Malaria vaccine research under way at Gryphon Sciences

Jan. 21, 1998

Johns Hopkins researchers synthesize antimalarial drug candidates

Jan. 21, 1998

Potential target for a malaria vaccine identified

Jan. 21, 1998

PDMP analogues studied for malaria inhibition

Jan. 21, 1998

Novel coronary artery disease gene therapy scheduled to enter clinical trials

Jan. 21, 1998

Pharmacological profile of broad-spectrum, nonopioid analgesic described by Abbott

Jan. 21, 1998

Novel antitumor cyanoguanidines with good oral bioavailability

Jan. 21, 1998

New chelating agent developed by Israeli researchers

Jan. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.